Patent details

Basic Information

Publication number:

EP3558458

PCT Application Number:

US2017063832

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP178847570

PCT Publication Number:

WO2018118369

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

GLYCERYL 3-HYDROXYBUTYRATES FOR MIGRAINE SYMPTOM MANAGEMENT

French Title of Invention:

3-HYDROXYBUTYRATES GLYCÉRIDES POUR LA GESTION DES SYMPTÔMES DE LA MIGRAINE

German Title of Invention:

GLYCERYL 3-HYDROXYBUTYRATE FÜR DAS MANAGEMENT VON MIGRÄNESYMPTOMEN

SPC Number:

Dates

Filing date:

30/11/2017

Grant date:

18/10/2023

EP Publication Date:

30/10/2019

PCT Publication Date:

28/06/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/10/2023

EP B1 Publication Date:

18/10/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

30/11/2023

Expiration date:

30/11/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/10/2023

 

 

Name:

Neuroenergy Ventures, Inc.

Address:

Gellis Law Group 641 Lexington Avenue , 14th Floor, New York, NY 10022, United States (US)

Inventor

Name:

HASHIM, Sami

Address:

United States (US)

Priority

Priority Number:

201615389828

Priority Date:

23/12/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61P 25/06; A61K 31/12; A61K 31/21; A61K 31/231;

Publication

European Patent Bulletin

Issue number:

202342

Publication date:

18/10/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages